Helixate NexGen

Factor VIII, recombinant · CSL Behring

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Helixate NexGen, covering 2015-03-20 to 2020-06-02. Get the full timeline:

Most recent: EMA Withdrawn: Helixate NexGen (octocog alfa) — Bayer AG